A survey of five antidepressant properties influencing clinician's treatment choices in MDD

George I. Papakostas, Lindsay A. Hallett, Juliana Smith, Eliana Tossani, Alessandra Mascarini, Alana M. Burns, Robert J. Birnbaum, Maurizio Fava, Jonathan E. Alpert

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Introduction: The goal of the present work was to examine how clinicians' perceptions of the properties of antidepressants may influence their choice of antidepressants when treating major depressive disorder (MDD). Methods: 273 of 682 (40%) clinicians attending a psychopharmacology review course responded to a questionnaire designed to explore their practices and perceptions with regards to antidepressant pharmacotherapy. Results: Most clinicians ranked efficacy (57.3%) as the most important factor when selecting antidepressants, followed by safety (23.0%), tolerability (9.4%), rapidity of action (5.2%), and cost (4.9%). However, when presented with hypothetical scenarios in which there was a difference in efficacy between two antidepressant agents, the relative safety, tolerability, and cost of the two agents significantly influenced the likelihood of choosing one antidepressant over another. In fact, clinicians required progressively greater differences in efficacy between two agents in order to select one antidepressant over another given a difference in terms of their safety than tolerability, or their tolerability than cost (p < 0.0001 all comparisons). Conclusions: When selecting an antidepressant, clinicians appear to be most influenced by efficacy, followed by safety. Rapidity of action and cost may be less salient considerations in clinical practice. Further research is necessary to elucidate factors that influence clinicians' choice of antidepressants.

Original languageEnglish (US)
Pages (from-to)169-172
Number of pages4
JournalNeuropsychiatric Disease and Treatment
Volume3
Issue number1
DOIs
StatePublished - 2007
Externally publishedYes

Fingerprint

Major Depressive Disorder
Antidepressive Agents
Safety
Costs and Cost Analysis
Therapeutics
Surveys and Questionnaires
Psychopharmacology
Drug Therapy

Keywords

  • Antidepressant
  • Depression
  • Preferences
  • Prescribing
  • Survey

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

A survey of five antidepressant properties influencing clinician's treatment choices in MDD. / Papakostas, George I.; Hallett, Lindsay A.; Smith, Juliana; Tossani, Eliana; Mascarini, Alessandra; Burns, Alana M.; Birnbaum, Robert J.; Fava, Maurizio; Alpert, Jonathan E.

In: Neuropsychiatric Disease and Treatment, Vol. 3, No. 1, 2007, p. 169-172.

Research output: Contribution to journalArticle

Papakostas, GI, Hallett, LA, Smith, J, Tossani, E, Mascarini, A, Burns, AM, Birnbaum, RJ, Fava, M & Alpert, JE 2007, 'A survey of five antidepressant properties influencing clinician's treatment choices in MDD', Neuropsychiatric Disease and Treatment, vol. 3, no. 1, pp. 169-172. https://doi.org/10.2147/nedt.2007.3.1.169
Papakostas, George I. ; Hallett, Lindsay A. ; Smith, Juliana ; Tossani, Eliana ; Mascarini, Alessandra ; Burns, Alana M. ; Birnbaum, Robert J. ; Fava, Maurizio ; Alpert, Jonathan E. / A survey of five antidepressant properties influencing clinician's treatment choices in MDD. In: Neuropsychiatric Disease and Treatment. 2007 ; Vol. 3, No. 1. pp. 169-172.
@article{6d507e51e93f4d60aad4a9442abdf86e,
title = "A survey of five antidepressant properties influencing clinician's treatment choices in MDD",
abstract = "Introduction: The goal of the present work was to examine how clinicians' perceptions of the properties of antidepressants may influence their choice of antidepressants when treating major depressive disorder (MDD). Methods: 273 of 682 (40{\%}) clinicians attending a psychopharmacology review course responded to a questionnaire designed to explore their practices and perceptions with regards to antidepressant pharmacotherapy. Results: Most clinicians ranked efficacy (57.3{\%}) as the most important factor when selecting antidepressants, followed by safety (23.0{\%}), tolerability (9.4{\%}), rapidity of action (5.2{\%}), and cost (4.9{\%}). However, when presented with hypothetical scenarios in which there was a difference in efficacy between two antidepressant agents, the relative safety, tolerability, and cost of the two agents significantly influenced the likelihood of choosing one antidepressant over another. In fact, clinicians required progressively greater differences in efficacy between two agents in order to select one antidepressant over another given a difference in terms of their safety than tolerability, or their tolerability than cost (p < 0.0001 all comparisons). Conclusions: When selecting an antidepressant, clinicians appear to be most influenced by efficacy, followed by safety. Rapidity of action and cost may be less salient considerations in clinical practice. Further research is necessary to elucidate factors that influence clinicians' choice of antidepressants.",
keywords = "Antidepressant, Depression, Preferences, Prescribing, Survey",
author = "Papakostas, {George I.} and Hallett, {Lindsay A.} and Juliana Smith and Eliana Tossani and Alessandra Mascarini and Burns, {Alana M.} and Birnbaum, {Robert J.} and Maurizio Fava and Alpert, {Jonathan E.}",
year = "2007",
doi = "10.2147/nedt.2007.3.1.169",
language = "English (US)",
volume = "3",
pages = "169--172",
journal = "Neuropsychiatric Disease and Treatment",
issn = "1176-6328",
publisher = "Dove Medical Press Ltd.",
number = "1",

}

TY - JOUR

T1 - A survey of five antidepressant properties influencing clinician's treatment choices in MDD

AU - Papakostas, George I.

AU - Hallett, Lindsay A.

AU - Smith, Juliana

AU - Tossani, Eliana

AU - Mascarini, Alessandra

AU - Burns, Alana M.

AU - Birnbaum, Robert J.

AU - Fava, Maurizio

AU - Alpert, Jonathan E.

PY - 2007

Y1 - 2007

N2 - Introduction: The goal of the present work was to examine how clinicians' perceptions of the properties of antidepressants may influence their choice of antidepressants when treating major depressive disorder (MDD). Methods: 273 of 682 (40%) clinicians attending a psychopharmacology review course responded to a questionnaire designed to explore their practices and perceptions with regards to antidepressant pharmacotherapy. Results: Most clinicians ranked efficacy (57.3%) as the most important factor when selecting antidepressants, followed by safety (23.0%), tolerability (9.4%), rapidity of action (5.2%), and cost (4.9%). However, when presented with hypothetical scenarios in which there was a difference in efficacy between two antidepressant agents, the relative safety, tolerability, and cost of the two agents significantly influenced the likelihood of choosing one antidepressant over another. In fact, clinicians required progressively greater differences in efficacy between two agents in order to select one antidepressant over another given a difference in terms of their safety than tolerability, or their tolerability than cost (p < 0.0001 all comparisons). Conclusions: When selecting an antidepressant, clinicians appear to be most influenced by efficacy, followed by safety. Rapidity of action and cost may be less salient considerations in clinical practice. Further research is necessary to elucidate factors that influence clinicians' choice of antidepressants.

AB - Introduction: The goal of the present work was to examine how clinicians' perceptions of the properties of antidepressants may influence their choice of antidepressants when treating major depressive disorder (MDD). Methods: 273 of 682 (40%) clinicians attending a psychopharmacology review course responded to a questionnaire designed to explore their practices and perceptions with regards to antidepressant pharmacotherapy. Results: Most clinicians ranked efficacy (57.3%) as the most important factor when selecting antidepressants, followed by safety (23.0%), tolerability (9.4%), rapidity of action (5.2%), and cost (4.9%). However, when presented with hypothetical scenarios in which there was a difference in efficacy between two antidepressant agents, the relative safety, tolerability, and cost of the two agents significantly influenced the likelihood of choosing one antidepressant over another. In fact, clinicians required progressively greater differences in efficacy between two agents in order to select one antidepressant over another given a difference in terms of their safety than tolerability, or their tolerability than cost (p < 0.0001 all comparisons). Conclusions: When selecting an antidepressant, clinicians appear to be most influenced by efficacy, followed by safety. Rapidity of action and cost may be less salient considerations in clinical practice. Further research is necessary to elucidate factors that influence clinicians' choice of antidepressants.

KW - Antidepressant

KW - Depression

KW - Preferences

KW - Prescribing

KW - Survey

UR - http://www.scopus.com/inward/record.url?scp=34249043253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249043253&partnerID=8YFLogxK

U2 - 10.2147/nedt.2007.3.1.169

DO - 10.2147/nedt.2007.3.1.169

M3 - Article

C2 - 19300547

AN - SCOPUS:34249043253

VL - 3

SP - 169

EP - 172

JO - Neuropsychiatric Disease and Treatment

JF - Neuropsychiatric Disease and Treatment

SN - 1176-6328

IS - 1

ER -